dest's overwrite journal

Status
Not open for further replies.
Ph1|, Head and Shoulders on lower chart, lol. can't help meself. BTW name of Bot Chart?

No Shampoo here, OK?

Like this:
HS.jpg
 
Ph1|, Head and Shoulders on lower chart, lol. can't help meself. BTW what's the generic moniker for the lower of your two charts to differentiate it from the upper one? BTW2 Ph1|, got views on this post? https://www.elitetrader.com/et/thre...t-be-in-the-market.360022/page-5#post-5418135

The lower chart shows the daily dividend-adjusted close price (calendar days from 20210309 and interpolated when the market was closed) minus the fitted parabola
Code:
y = 67.000846862793  +  0.133354142308235 * x  +  0.000296262296615168 * x * x
labeled dataminustrend and the three fitted cosine waves
Code:
       1.60150742530823 * cos(twopi / 80.7636929812316 * x  +  0.632126867771149)
    +  1.32835626602173 * cos(twopi / 30.1399119361322 * x  +  4.50122880935669)
    +  0.997597217559814 * cos(twopi / 22.5603293330753 * x  +  5.36369609832764)
labeled detrended. So, it's not a chart to be interpreted as a conventional head and shoulders.

Since this model is fitting prices and prices change, it will likely degrade and need to be recalculated ideally at every bar.
 
BTW what's the generic moniker for the lower of your two charts to differentiate it from the upper one?
Synonyms of moniker · alias, · byname, · cognomen, · epithet, · handle, · nickname, · sobriquet · (also soubriquet), ...
 
I glanced at a 3-MO chart of NVO, and it make me nervous. Granted, that is based on chart patterns I see on indices. I don't follow single-stock charts. So who knows? Dest must know, because he bolded his call.
I think the thesis is on the expected success of a newly released drug. The implicit bet is that demand for the drug will be greater than what is expected on the street, which will result in:
1) analyst revisions moving higher as more information comes to light
2) a potential beat & raise (beat revenue & raise guidance for the year)
Which would result in post-earnings announcement drift (major driver of momentum), as future FCF estimates would need to revised higher, causing the stock price to look undervalued in DCF and multiples models. This would drive buying activity by funds that invest in value, biotech, and growth. Furthermore, if the stock price does appreciate rapidly, then it'll gain a larger share of market cap/industry, making it benefit from passive investors.
 
what kind of filter do you use on price? kalman?

This method results in a function that tries to create a least squares fit of raw prices. The only input to the function is time represented as the relative number of bars since the beginning of the fitted prices. That lets the function be extrapolated to any future time.

The function has a parabola plus three cosine waves. The filtering to get detrended raw price data (dataminustrend in the second image of this post) is subtract the parabola value for a given time from the raw price.

Here are a few posts describing this:
https://www.elitetrader.com/et/thre...dict-market-moves.357176/page-36#post-5358066
https://www.elitetrader.com/et/thre...-price-prediction-models.357511/#post-5359400
https://www.elitetrader.com/et/threads/ta-like-catching-a-greased-pig.359026/#post-5393480
https://www.elitetrader.com/et/threads/ta-like-catching-a-greased-pig.359026/page-2#post-5394477
https://www.elitetrader.com/et/threads/whats-your-favorite-chart-pattern.359850/page-2#post-5413673
 
NVO killer 90-day chart... if I were to trade it, (not a recommendation) I'd go long over 88 or short under 84.

View attachment 263125

It is fascinating to me how we all see charts differently. Ken, looking at this chart, I would do the opposite of what you said, based on previous movement...

Middle of June was a peak of ~85, then a couple weeks later hit a low of ~81.5. If we were to hit 84 I'd long, and short at 88, based on previous cycle. Of course, that is just pure chart TA. I don't trade single stocks, and I hate shorting, heh.
 
Status
Not open for further replies.
Back
Top